Kelly Malcom

Lead Research Communicator

Malcom is a lead research communicator for Michigan Medicine and research communications strategist for the U-M Medical School, with more than 20 years of experience in strategic communications, marketing, and health and science writing. She covers the basic science departments, pulmonary and critical care medicine, infectious disease, pathology and anesthesiology. Contact: [email protected]

pill attacking coronavirus
Health Lab

Prostate cancer drug shows promise against COVID

Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.
nasal spray
Health Lab

An adjuvanted intranasal vaccine for COVID-19 protects both young and old mice

A collaborative research effort led by the University of Michigan and the Icahn School of Medicine at Mount Sinai has resulted in a nasal vaccine adjuvant that stops infection in both young and old mice.
sperm purple glowing
Health Lab

Modifications to amino acids in sperm could be behind infertility

Researchers at the University of Michigan are now delving into the molecular-level details of sperm formation, with a particular focus on how abnormalities in this process might lead to male-factor infertility.
ant close up brown black background
Health Lab

Research hints at how fungus farming ants keep their gardens healthy

Investigators find that these specific ants sniff out diseased fungus by detecting chemicals called peptaibols.
hospital bed
Health Lab

During the pandemic, hospital transfers were complex and distressing

A study from the University of Michigan Center for Bioethics & Social Sciences in Medicine examined the factors that went into this decision-making—and the moral distress that often resulted from it.
bacteria blue yellow
Health Lab

What turns fungus from friend to foe?

Scientists have wondered whether there are differences in the types of yeast that become pathogenic. A study from the U-M Medical School Department of Microbiology and Immunology finds that the colonizing strains are very similar to pathogenic strains.
dna strand in blue grainy off white background yellow spots
Health Lab

A new regulator of innate immunity identified

One of the most important protein complexes in mammals involved in ERAD is called SEL1L-HRD1. Recent research finds that this protein complex helps regulate another critical protein involved in innate immunity, called STING, at the endoplasmic reticulum.
older man on cpap machine sitting on bed
Health Lab

Controlling elevated carbon dioxide improves survival

A Michigan Medicine study finds controlling elevated carbon dioxide improves survival in patients.
fruitfly hunger refrigerator apple orange
Health Lab

The feeling of hunger itself may slow aging in flies

Scientists say these findings may also apply to other species
blue cells
Health Lab

How SARS-CoV-2 sets up a literal shop inside cells to cause infection

A highly complicated experiment designed to reveal how SARS-CoV-2 causes infection by hijacking cellular machinery is published by a team of investigators at Michigan Medicine.
black room with person visual far away walking towards glowing light
Health Lab

Evidence of conscious-like activity in the dying brain

A Michigan Medicine study provides early evidence of a surge of activity correlated with consciousness in the dying brain.
brain blue yellow spots
Health Lab

Connecting the brain’s hot zone

A Michigan Medicine study takes a closer look at the neurobiology of psychedelic experiences.
dna yellow blue
Health Lab

Study reveals pivotal RNA modification in mouse embryos

A Michigan Medicine study reveals pivotal RNA modification in mouse embryos.
hospital bed yellow blue
Health Lab

Who goes to the ICU and why?

A Michigan Medicine study tries to understand why different hospitals use the intensive care unit more than others.
News Release

University of Michigan receives $71M NIH grant to advance clinical & translational science

MICHR to tackle goal of diversifying and improving research to speed therapies for benefit of all patients
  • 8
  • 9
  • 10